Autonomous AI Screening Flags Unreliable Lyme Test Results

Computational point-of-care sensors utilizing autonomous AI screening have successfully flagged unreliable Lyme disease test results. This technology boosts diagnostic sensitivity to 95.7%, significantly improving access to accurate testing outside centralized medical facilities. The advancement represents a major step forward in rapid patient diagnostics and healthcare accessibility.